Category Archives: Stem Cell Videos

Dean Tozer of Shire Regenerative Medicine - at Stem Cells USA Regenerative Medicine Congress 2012
Dean Tozer, Senior Vice President of Corporate Development at Shire Regenerative Medicine, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Going all-in: Shire #39;s $750M bet on Shire Regenerative Medicine. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:18:23More inScience Technology

Read the original:
Dean Tozer of Shire Regenerative Medicine - at Stem Cells USA

William Prather of Pluristem on treating Aplastic Anemia with stem cells - at Stem Cells USA 2012
William Prather, Sr. VP Corporate Development at Pluristem, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Treating Aplastic Anemia with PLX Stem Cells. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:21:02More inScience Technology

Read this article:
William Prather of Pluristem on treating Aplastic Anemia with stem cells - at Stem Cells USA 2012 - Video

Using Stem Cells to Study Autism
(Visit: http://www.uctv.tv Dr. Dolmetsch #39;s group has developed methods for using induced pluripotent stem cells to study human brain development and for identifying cell and molecular phenotypes associated with disease. His laboratory has also made significant contributions to calcium signaling including the identification of signaling pathways that connect calcium channels to gene activation and the identification of the mechanisms of activation of store operated calcium channels. The lab has also developed several new technologies to study cell signaling including enzyme complementation systems to measure protein interactions in cells and light-activated signaling proteins to control biochemical cascades. Series: "MIND Institute Lecture Series on Neurodevelopmental Disorders" [Health and Medicine] [Show ID: 24425]From:UCtelevisionViews:4 2ratingsTime:01:12:41More inEducation

View post:
Using Stem Cells to Study Autism - Video

Teresa Leezer of Rhinocyte on neurodegenerative conditions - at Stem Cells USA RM Congress 2012
Teresa Leezer, COO of Rhinocyte, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Using autologous olfactory epithelial cells to treat neurodegenerative conditions. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:14:58More inScience Technology

Continued here:
Teresa Leezer of Rhinocyte on neurodegenerative conditions - at Stem Cells USA

Edward Lanphier of Sangamo on engineering genetic cures - at Stem Cells USA RM Congress 2012
Edward Lanphier, CEO of Sangamo, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Engineering genetic cures: employing zinc finger nucleases (ZFNs) in stem cells. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:24:15More inScience Technology

Read more:
Edward Lanphier of Sangamo on engineering genetic cures - at Stem Cells USA

Michael West of BioTime on hES cell-based therapies - at Stem Cells USA RM Congress 2012
Michael West, CEO of BioTime, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Second generation hES cell-based therapies: achieving purity and scalability in the midst of diversity. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:23:31More inScience Technology

The rest is here:
Michael West of BioTime on hES cell-based therapies - at Stem Cells USA

Ed Field of Cytomedix on biotech collaboration in RM - at Stem Cells USA RM Congress 2012
Ed Field, Chief Operating Officer of Cytomedix, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Biotech collaboration in RM: Cytomedix #39;s acquisition of Aldagen. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:24:03More inScience Technology

Read more:
Ed Field of Cytomedix on biotech collaboration in RM - at Stem Cells USA

Mathew Vincent of ACT on hESC derived RPE cells - at Stem Cells USA RM Congress 2012
Mathew Vincent, Director of Business Development at Advanced Cell Technology, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Meaningful clinical results with hESC derived RPE cells in patients with SMD and Dry AMD. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:25:03More inScience Technology

Continue reading here:
Mathew Vincent of ACT on hESC derived RPE cells - at Stem Cells USA

Donna Skerrett of Mesoblast on adult stem cell therapies - at Stem Cells USA RM Congress 2012
Donna Skerrett, Chief Medical Officer of Mesoblast, presented a case study on Mesoblast and their adult stem cell therapy at the Stem Cells USA Regenerative Medicine Congress 2012. The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:21:30More inScience Technology

See the original post here:
Donna Skerrett of Mesoblast on adult stem cell therapies - at Stem Cells USA

What Are Stem Cells - Mexico Specialist
http://www.mexicohealth.com The video shows a stem cell specialist from Mexico explaining in layman terms the stems cells and how they #39;re harvested. This specialist operates from Tijuana where he has been dedicated to finding a perfect recipe for different life threatening conditions and he has tasted success. With an astonishingly high initial response of over 80%, the doctor has cured over 40 patients for conditions like multiple sclerosis, brain damage, eye problems and cardiac problems. To get a free quote by Mexico specialist in stem cell therapy, click the link above. Related Searches: What are stem cells stem cell definitionFrom:mexicohealthViews:3 0ratingsTime:01:05More inPeople Blogs

See original here:
What Are Stem Cells - Mexico Specialist - Video